THE UNIVERSITY OF CHICAGO

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 153110
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5669
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 54113
 
  
 
C07K PEPTIDES 5185
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 49157
 
  
 
B01L CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 2137
 
  
 
G06K RECOGNITION OF DATA; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS 20178
 
  
 
B01J CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 1891
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1683
 
  
 
B01F MIXING, e.g. DISSOLVING, EMULSIFYING, DISPERSING 1527

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0073,062 COMPOSITIONS AND METHODS FOR IDENTIFYING ENDOGENOUS DNA-DNA INTERACTIONSSep 15, 17Mar 15, 18[C12Q, C40B]
2018/0066,031 ENZYMATICALLY-CLEAVABLE PEPTIDE AMPHIPHILESSep 01, 17Mar 08, 18[C07K]
2018/0044,385 METHODS AND COMPOSITIONS INVOLVING PROTEIN G VARIANTSOct 16, 15Feb 15, 18[G01N, C07K]
2018/0037,889 ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHODS OF TREATING DYSTROPHIESSep 07, 17Feb 08, 18[A61K, C12N]
2018/0038,868 BETA-CATENIN INHIBITORS IN CANCER IMMUNOTHERAPYMar 04, 16Feb 08, 18[A61K, C12Q, G01N]
2018/0028,224 MALLET WITH RADIOLUCENT HEADJul 26, 17Feb 01, 18[A61B]
2018/0028,553 USE OF STING AGONIST AS CANCER TREATMENTOct 13, 17Feb 01, 18[A61K]
2018/0008,594 USE OF OPIOID ANTAGONISTSJul 07, 17Jan 11, 18[A61K, G01N]
2017/0368,551 DEVICE AND METHOD FOR PRESSURE-DRIVEN PLUG TRANSPORT AND REACTIONAug 10, 17Dec 28, 17[B01L, B01J, B01F]
2017/0363,607 AMORPHOUS, POROUS SILICON MATERIALS AND RELATED METHODSJun 14, 17Dec 21, 17[C23C, G01N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9914847 Resin composition for forming a phase-separated structure, and method of producing structure containing phase-separated structureJun 17, 16Mar 13, 18[B05D, C09D, B01J]
9916958 Alkali semi-metal films and method and apparatus for fabricating themJan 29, 15Mar 13, 18[H01J, C23C, G01N, H02S]
9907850 Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune responseDec 14, 15Mar 06, 18[A61K, C07K]
9911584 Batch production of microchannel plate photo-multipliersMar 24, 17Mar 06, 18[H01J, H01L]
9889446 Device and method for pressure-driven plug transport and reactionMay 04, 17Feb 13, 18[C12Q, C12P, B82Y, B01L, G01N, B01J, B01F]
9885050 Molecular affinity clamp technology and uses thereofNov 10, 08Feb 06, 18[C12N, G01N, C07K]
9877976 Methods and compositions for protection of cells and tissues from computed tomography radiationSep 16, 11Jan 30, 18[A61K, A61B]
9882001 Materials and methods for the preparation of nanocompositesMay 16, 12Jan 30, 18[H01L, B82Y, B01J]
9861619 Antibiotic methods and compositions for bacteria infectionsNov 01, 13Jan 09, 18[A61K]
9855302 Treatment of cancer by manipulation of commensal microfloraJun 01, 16Jan 02, 18[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0273,954 METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONSAbandonedJun 09, 17Sep 28, 17[A61K]
2016/0317,631 INCREASED T-CELL TUMOR INFILTRATION AND ERADICATION OF METASTASES BY MUTANT LIGHTAbandonedJan 22, 16Nov 03, 16[A61K]
2016/0297,986 THREE DIMENSIONAL BLOCK-COPOLYMER FILMS FORMED BY ELECTROHYDRODYNAMIC JET PRINTING AND SELF-ASSEMBLYAbandonedAug 14, 14Oct 13, 16[B41J, C09D]
2016/0287,623 USE OF STING AGONIST AS CANCER TREATMENTAbandonedNov 19, 14Oct 06, 16[A61K]
2016/0250,327 METHODS AND COMPOSITIONS TO REDUCE LIVER DAMAGE ASSOCIATED WITH CONDITIONS OR THERAPIES THAT AFFECT THE IMMUNE SYSTEMAbandonedMar 28, 16Sep 01, 16[A61K]
2016/0204,348 SEMICONDUCTING POLYMERS AND TERNARY BLENDS THEREOFAbandonedJan 30, 15Jul 14, 16[H01L, C08G]
2016/0194,363 Compositions and Methods Related to Protein A (SpA) VariantsAbandonedMar 04, 16Jul 07, 16[A61K, C07K]
2016/0074,373 METHODS AND COMPOSITIONS FOR INHIBITING HUMAN COPPER TRAFFICKING PROTEINS ATOX1 AND CCSAbandonedJan 23, 14Mar 17, 16[A61K]
2016/0074,497 STAPHYLOCOCCUS LIVE CELL VACCINESAbandonedMay 02, 14Mar 17, 16[A61K, C07K]
2016/0074,488 METHODS AND COMPOSITIONS INVOLVING FIBRILLIZING POLYPEPTIDES FOR NANOFIBERSAbandonedNov 25, 15Mar 17, 16[A61K]
2016/0040,240 CACNA1C ALLELE AND TREATMENT OF MOOD DISORDERSAbandonedAug 11, 15Feb 11, 16[A61K, C12Q]
2016/0029,622 Plant Pathogen ResistanceAbandonedOct 16, 15Feb 04, 16[C05G, A01N]
2015/0246,024 METHODS AND COMPOSITIONS FOR INHIBITING GRAM POSITIVE BACTERIAAbandonedAug 20, 13Sep 03, 15[A61K]
2015/0239,184 SOLVENT ANNEALING OF BLOCK COPOLYMER FILMS UNDER SUPER-SATURATED ATMOSPHERESAbandonedFeb 21, 14Aug 27, 15[B29C]
2015/0231,093 METHODS AND COMPOSITIONS FOR COUNTERMEASURES AGAINST RADIATIONAbandonedFeb 17, 15Aug 20, 15[A61K]
2015/0190,523 BIOAVAILABILITY OF ORAL METHYLNALTREXONE INCREASES WITH A PHOSPHATIDYLCHOLINE-BASED FORMULATIONAbandonedMar 13, 13Jul 09, 15[A61K]
2015/0164,957 CONVERSION OF CARDIOMYOCYTES INTO FAST CONDUCTING CARDIOMYOCYTES OR SLOW CONDUCTING NODAL CELLSAbandonedMay 17, 13Jun 18, 15[A61K, C12N, G01N]
2015/0157,692 METHODS OF TREATING OBESITYAbandonedMay 23, 13Jun 11, 15[A61K, A23L, C12N, C07K]
2014/0375,671 METHOD, SYSTEM, SOFTWARE AND MEDIUM FOR ADVANCED IMAGE-BASED ARRAYS FOR ANALYSIS AND DISPLAY OF BIOMEDICAL INFORMATIONAbandonedNov 28, 12Dec 25, 14[G06T, G09G, G06F]
2014/0377,830 System for the Production of Methane From CO2AbandonedSep 08, 14Dec 25, 14[C12P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.